Zhao Zhi-Qing, Vinten-Johansen Jakob
Department of Cardiothoracic Surgery, The Carlyle Fraser Heart Center/Crawford Long Hospital, Emory University School of Medicine, 550 Peachtree St. NE, Atlanta, GA 30308-2225, USA.
Cardiovasc Res. 2002 Aug 15;55(3):438-55. doi: 10.1016/s0008-6363(02)00442-x.
Necrosis and apoptosis are two forms of cell death in the myocardium that have been associated with ischemia and reperfusion. Although it has been well documented that necrosis, as a major form of myocyte cell death, rapidly leads to a destruction of a large group of cells after myocardial ischemia and reperfusion, the induction of apoptosis in myocardium, primarily triggered during reperfusion, may independently contribute to the extension of cell death (i.e. infarction) in a dynamic manner. Ischemic preconditioning (IP), an endogenous protective mechanism rapidly evoked by a brief period of ischemia, is recognized for its protection in limiting myocardial necrosis, but has also shown a profound inhibition in apoptosis. While much research has been done on the reduction of necrosis by IP, there remains no clear understanding of the time course of inhibition of apoptosis by IP after long-term reperfusion. In this review, we will show the time course of necrosis and apoptosis during reperfusion, focus on the role of apoptosis in the extension of lethal myocyte injury, and summarize the potential mechanisms involved in reducing apoptosis by IP. 'Classic' or 'early' IP has been shown to reduce apoptosis in part by inhibiting inflammatory cell activation and altering the expression of anti- and pro-apoptotic proteins as well as protein kinase C activity. It remains unknown, however, whether delayed IP participates in the attenuation of apoptosis in addition to necrosis. The demonstration of a 'window of opportunity' in inhibiting apoptosis by IP will provide new directions in research investigating mechanisms underlying myocyte cell death during reperfusion, and translate this information into new treatment approaches for reducing the extent of ischemia/reperfusion injury.
坏死和凋亡是心肌细胞死亡的两种形式,与缺血和再灌注相关。虽然已有充分证据表明,坏死作为心肌细胞死亡的主要形式,在心肌缺血和再灌注后会迅速导致大量细胞破坏,但心肌细胞凋亡的诱导主要发生在再灌注期间,可能会以动态方式独立促进细胞死亡(即梗死)范围的扩大。缺血预处理(IP)是一种由短暂缺血迅速诱发的内源性保护机制,其对限制心肌坏死的保护作用已得到认可,同时也显示出对凋亡有显著抑制作用。虽然关于IP减少坏死的研究很多,但对于长期再灌注后IP抑制凋亡的时间进程仍缺乏清晰认识。在本综述中,我们将展示再灌注期间坏死和凋亡的时间进程,关注凋亡在致命性心肌细胞损伤扩大中的作用,并总结IP减少凋亡所涉及的潜在机制。“经典”或“早期”IP已被证明部分通过抑制炎症细胞激活、改变抗凋亡和促凋亡蛋白的表达以及蛋白激酶C活性来减少凋亡。然而,延迟IP除了减少坏死外是否参与凋亡的减轻仍不清楚。证明IP抑制凋亡存在“机会窗口”将为研究再灌注期间心肌细胞死亡机制提供新方向,并将这些信息转化为减少缺血/再灌注损伤程度的新治疗方法。